logo

For the Inventor, By the Inventor

Munich, Germany

Christoph J Auernhammer

This inventor holds 2 USPTO granted patents. Top assignee: Cedars-Sinai Medical Center. Active years: 2003-2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christoph J Auernhammer. Retrieved from https://idiyas.com/inventor/christoph-j-auernhammer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2

% Patents Active = 50.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Munchen-Pasing, DE (2003)
  • München-Pasing, DE (2005)

Company Filing History:

goldMedal2 out of 628 
 
Cedars-Sinai Medical Center
 patents

Years Active: 2003-2005

Loading Chart...
2 patents (USPTO):Explore Patents
1. 6943018 - Transgenic expression from a SOCS-3 promoter in vertebrate cells (2005-09-13),
2. 6541244 - Suppressor of cytokine signaling (SOCS)-3 promoter and methods for its use in genetic therapy in humans (2003-04-01),

Title: Christoph J Auernhammer: Innovator in Genetic Therapy

Introduction

Christoph J Auernhammer is a notable inventor based in Munich, Germany. He has made significant contributions to the field of genetic therapy, particularly through his innovative patents. With a total of two patents to his name, Auernhammer's work focuses on the application of the SOCS-3 promoter in vertebrate cells.

Latest Patents

Auernhammer's latest patents include groundbreaking research on transgenic expression from a SOCS-3 promoter in vertebrate cells. This patent discloses a transgenic vertebrate cell containing a nucleic acid construct that comprises a murine SOCS-3 promoter or its operative fragments. Additionally, he has developed a method for using the SOCS-3 promoter in genetic therapy for humans. This includes a nucleic acid construct that can treat growth retardation or acceleration disorders, autoimmune diseases, and inflammatory conditions in human subjects. His work also involves a kit for genetically modifying vertebrate cells, which includes a polynucleotide comprising the murine SOCS-3 promoter sequence.

Career Highlights

Christoph J Auernhammer is currently associated with Cedars-Sinai Medical Center, where he continues to advance his research in genetic therapy. His innovative approaches have positioned him as a key figure in the field, contributing to the understanding and treatment of various medical conditions.

Collaborations

Auernhammer collaborates with Shlomo Melmed, enhancing the impact of his research through shared expertise and knowledge.

Conclusion

Christoph J Auernhammer's contributions to genetic therapy through his patents and research at Cedars-Sinai Medical Center highlight his role as an influential inventor in the field. His work promises to advance therapeutic options for various health conditions, showcasing the importance of innovation in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…